Cargando…

MAFLD and CKD: An Updated Narrative Review

Accumulating evidence now indicates that non-alcoholic fatty liver disease (NAFLD), which is the most common chronic liver disease observed in clinical practice worldwide, is independently associated with an increased risk of incident chronic kidney disease (CKD). Given that NAFLD is linked to insul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantovani, Alessandro, Lombardi, Rosa, Cattazzo, Filippo, Zusi, Chiara, Cappelli, Davide, Dalbeni, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266672/ https://www.ncbi.nlm.nih.gov/pubmed/35806010 http://dx.doi.org/10.3390/ijms23137007

Ejemplares similares

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

COVID-19 outbreak in children and/or adolescents
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2022)

COVID-19 and MAFLD/NAFLD: An updated review
por: Nowroozi, Ali, et al.
Publicado: (2023)

Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Treatments for NAFLD: State of Art
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
por: Barchetta, Ilaria, et al.
Publicado: (2020)

Role of Insulin Resistance in MAFLD
por: Sakurai, Yoshitaka, et al.
Publicado: (2021)

MAFLD and Celiac Disease in Children
por: Scapaticci, Serena, et al.
Publicado: (2023)

Obesity and CKD in Sub-Saharan Africa: A Narrative Review
por: Oluyombo, Rotimi, et al.
Publicado: (2021)

Narrative Review of the Relationship Between CKD and Diabetic Foot Ulcer
por: Bonnet, Jean-Baptiste, et al.
Publicado: (2021)

The Gut Microbiome and Ferroptosis in MAFLD
por: Ji, Jie, et al.
Publicado: (2023)

Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
por: Sangro, Paloma, et al.
Publicado: (2023)

Recent Developments in NAFLD
por: Mantovani, Alessandro, et al.
Publicado: (2022)

A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD
por: Metzger, Maureen, et al.
Publicado: (2021)

MAFLD: How is it different from NAFLD?
por: Gofton, Cameron, et al.
Publicado: (2023)

Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter
por: Marc, Luciana, et al.
Publicado: (2022)

The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study
por: Dalbeni, Andrea, et al.
Publicado: (2023)

Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia
por: Bevilacqua, Michele, et al.
Publicado: (2023)

Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review
por: Francis, Anna, et al.
Publicado: (2015)

Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
por: Cordeiro, Adryana, et al.
Publicado: (2022)

Iron-Deficiency Anemia in CKD: A Narrative Review for the Kidney Care Team
por: Hain, Debra, et al.
Publicado: (2023)

The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
por: Abou Assi, Reem, et al.
Publicado: (2021)

CKD and Pregnancy Outcomes in Africa: A Narrative Review
por: Maule, Sophie P., et al.
Publicado: (2020)

Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19–Related Disease
por: Bevilacqua, Michele, et al.
Publicado: (2022)

From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
por: Boccatonda, Andrea, et al.
Publicado: (2023)

Coronavirus disease 2019 (COVID-19): we don’t leave women alone
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Survival of Older Patients With Advanced CKD Managed Without Dialysis: A Narrative Review
por: Chou, Angela, et al.
Publicado: (2022)

SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
por: Thomas, Merlin C, et al.
Publicado: (2023)

From MAFLD to hepatocellular carcinoma and everything in between
por: Bae, Sarah Da Won, et al.
Publicado: (2022)

Advancements in MAFLD Modeling with Human Cell and Organoid Models
por: Wang, Shi-Xiang, et al.
Publicado: (2022)

MAFLD: an optimal framework for understanding liver cancer phenotypes
por: Crane, Harry, et al.
Publicado: (2023)

Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
por: Filipovic, Branka, et al.
Publicado: (2023)

MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023)

Chronic Kidney Disease-Associated Itch (CKD-aI) in Children—A Narrative Review
por: Reszke, Radomir, et al.
Publicado: (2021)

Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder
por: Patel, Rahul N., et al.
Publicado: (2023)

The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review
por: Talotta, Rossella, et al.
Publicado: (2017)

Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD
por: Clare, Kathleen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_573urtk1qncdul2l7fpcj5eg24